read more

first_img Technology | Mammography Reporting Software | July 25, 2019 Hologic Partners With MagView to Develop Unifi EQUIP Solution Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an… read more July 8, 2009 – The Susan G. Komen for the Cure, a leading breast cancer organization, is announcing millions of dollars in long-term grant funding for research on whether individuals can prevent development of their own cancers.The foundation is asking the scientific community for proposals for long-term research grants – some as large as $5 million – to study everything from the role of natural products to diets to breast cancer vaccines. The foundation aims to work on strategies to prevent breast cancer entirely, or at least pinpoint the environmental and lifestyle issues that may contribute to breast cancer.The research will be funded through Komen’s Promise Grants: multiyear, multimillion dollar projects geared to answer the toughest questions in breast cancer science today.Introduced in 2008, Promise Grants require collaboration across a wide range of disciplines – scientists, medical professionals, caregivers, public health specialists and advocates – who normally may not work together. These teams conduct research with the highest potential to deliver treatments for breast cancer more quickly and for this new Promise Grant to find ways to prevent breast cancer.Komen’s $450 million in research funding since its founding in 1982 has touched every major development in breast cancer treatments during the past 27 years. In the last three years alone, Komen has invested more than $230 million in research projects in the U.S. and internationally.For more information: www5.komen.org/researchgrants/grantprograms.html FacebookTwitterLinkedInPrint分享 Technology | Breast Biopsy Systems | July 24, 2019 Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its… read more Image courtesy of Imago Systems read more News | Mammography | August 14, 2019 Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year… read more News | PACS | August 09, 2019 Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and… read more News | Ultrasound Women’s Health | July 11, 2019 FDA Clears Koios DS Breast 2.0 AI-based Software Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA). News | Mammography Reporting Software | July 26, 2019 Ikonopedia Releases Automated Combined Reporting Package at AHRA Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured… read more News | Breast Imaging | August 02, 2019 Volpara to Distribute Screenpoint Medical’s Transpara AI Solution Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint’s Transpara… read more News | Artificial Intelligence | August 13, 2019 Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that… read more IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology. Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev AI Models Predict Breast Cancer With Radiologist-level Accuracy Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer… read more Related Content Technology | Artificial Intelligence | July 18, 2019 Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded… read more Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire. News | July 08, 2009 Susan G. Komen Funds Research on Preventing Cancer last_img

Leave a Reply

Your email address will not be published. Required fields are marked *